Mette Vesterhus

4.8k total citations · 1 hit paper
53 papers, 2.0k citations indexed

About

Mette Vesterhus is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mette Vesterhus has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 32 papers in Epidemiology and 24 papers in Surgery. Recurrent topics in Mette Vesterhus's work include Liver Diseases and Immunity (34 papers), Liver Disease Diagnosis and Treatment (32 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). Mette Vesterhus is often cited by papers focused on Liver Diseases and Immunity (34 papers), Liver Disease Diagnosis and Treatment (32 papers) and Pediatric Hepatobiliary Diseases and Treatments (10 papers). Mette Vesterhus collaborates with scholars based in Norway, United States and United Kingdom. Mette Vesterhus's co-authors include Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Odd Helge Gilja, Johannes R. Hov, Anders Molven, Pål R. Njølstad, Roald Flesland Havre, Helge Ræder and Kirsten Muri Boberg and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mette Vesterhus

49 papers receiving 2.0k citations

Hit Papers

Primary sclerosing cholangitis – a comprehensive review 2017 2026 2020 2023 2017 100 200 300 400 500

Peers

Mette Vesterhus
Mette Vesterhus
Citations per year, relative to Mette Vesterhus Mette Vesterhus (= 1×) peers Alessandro Musso

Countries citing papers authored by Mette Vesterhus

Since Specialization
Citations

This map shows the geographic impact of Mette Vesterhus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Vesterhus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Vesterhus more than expected).

Fields of papers citing papers by Mette Vesterhus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Vesterhus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Vesterhus. The network helps show where Mette Vesterhus may publish in the future.

Co-authorship network of co-authors of Mette Vesterhus

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Vesterhus. A scholar is included among the top collaborators of Mette Vesterhus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Vesterhus. Mette Vesterhus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hov, Johannes R., Eystein S. Husebye, Trine Folseraas, et al.. (2025). Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 60(2). 165–173.
2.
Mol, Bregje, Martti Färkkilâ, Trine Folseraas, et al.. (2024). DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study. Journal of Crohn s and Colitis. 18(Supplement_1). i97–i98. 2 indexed citations
3.
Hussain, Nasir, Christopher Ma, Gideon M. Hirschfield, et al.. (2024). Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis. BMJ Open. 14(6). e080143–e080143. 3 indexed citations
4.
Wacker, Eike Matthias, Florian Uellendahl-Werth, Olaf Wolkenhauer, et al.. (2023). Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis. JHEP Reports. 6(2). 100988–100988. 2 indexed citations
5.
Folvik, Geir, et al.. (2022). Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up. Scandinavian Journal of Gastroenterology. 58(5). 512–520. 5 indexed citations
6.
Vesterhus, Mette, Kristin Kaasen Jørgensen, Svein Oskar Frigstad, John Willy Haukeland, & Tom H. Karlsen. (2022). Vi trenger en ny strategi for leversykdom. Tidsskrift for Den norske legeforening. 142(3). 2 indexed citations
7.
Laursen, Tea Lund, Rasmus Pihl, Anne Troldborg, et al.. (2022). Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases. Journal of Clinical and Translational Hepatology. 10(5). 796–802. 8 indexed citations
8.
Olafsdottir, E, et al.. (2021). Controlled Attenuation Parameter in Healthy Individuals Aged 8–70 Years. SHILAP Revista de lepidopterología. 7(1). E6–E13. 5 indexed citations
9.
Wiencke, Kristine, Ida Torunn Bjørk, Odd Helge Gilja, et al.. (2021). Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF. JHEP Reports. 3(5). 100328–100328. 21 indexed citations
10.
Mousa, Omar Y., Brian D. Juran, Bryan M. McCauley, et al.. (2020). Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. Hepatology. 74(1). 281–295. 68 indexed citations
11.
Lohse, Ansgar W., Marcial Sebode, Marianne Hørby Jørgensen, et al.. (2020). Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology. 73(6). 1496–1506. 60 indexed citations
12.
Gilja, Odd Helge, et al.. (2020). Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems. Ultrasound in Medicine & Biology. 46(8). 1854–1864. 8 indexed citations
13.
Vesterhus, Mette, Mette Juul Nielsen, Johannes R. Hov, et al.. (2020). Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease. JHEP Reports. 3(1). 100178–100178. 12 indexed citations
14.
Dhillon, Amandeep K., Andreas E. Kremer, Martin Kummen, et al.. (2019). Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis. Scientific Reports. 9(1). 8450–8450. 7 indexed citations
15.
16.
Karlsen, Tom H., Trine Folseraas, Douglas Thorburn, & Mette Vesterhus. (2017). Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology. 67(6). 1298–1323. 527 indexed citations breakdown →
18.
Hausken, Trygve, et al.. (2016). Ultrasound and Point Shear Wave Elastography in Livers of Patients with Primary Sclerosing Cholangitis. Ultrasound in Medicine & Biology. 42(9). 2146–2155. 13 indexed citations
19.
Johansson, Bente B., Janniche Torsvik, Lise Bjørkhaug, et al.. (2011). Diabetes and Pancreatic Exocrine Dysfunction Due to Mutations in the Carboxyl Ester Lipase Gene-Maturity Onset Diabetes of the Young (CEL-MODY). Journal of Biological Chemistry. 286(40). 34593–34605. 74 indexed citations
20.
Haldorsen, Ingfrid S., Mette Vesterhus, Helge Ræder, et al.. (2008). Lack of pancreatic body and tail in HNF1B mutation carriers. Diabetic Medicine. 25(7). 782–787. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026